Advertisement
Screener

Tempest Therapeutics, Inc. (TPST) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

Tempest Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)

Tempest Therapeutics, Inc. (TPST) reported Basic Shares Outstanding (Weighted Average) of 15.22 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13

  • Tempest Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 15.22M shares, a 300.32% increase year-over-year.
  • Tempest Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 10.93M shares, a 217.99% increase year-over-year.
  • Tempest Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 4.91M shares, a 55.61% increase year-over-year.
  • Tempest Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 4.44M shares, a 123.67% increase year-over-year.
  • Tempest Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 4.15M shares, a 93.35% increase from fiscal 2024.
  • Tempest Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 2.15M shares, a 86.08% decline from fiscal 2023.
  • Tempest Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 15.42M shares, a 33.49% increase from fiscal 2022.
  • Tempest Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 11.55M shares, a 204.70% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 6 month as first filedWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-3015.22M shares
10-Q · filed 2026-08-13
13.09M shares
10-Q · filed 2026-08-13
10.35M shares
derived: average of 3 quarters · filed 2026-08-13
8.88M shares
derived: average of 4 quarters · filed 2026-08-13
2026-03-3110.93M shares
10-Q · filed 2026-05-14
7.92M shares
derived: average of 2 quarters · filed 2026-05-14
6.76M shares
derived: average of 3 quarters · filed 2026-05-14
6.02M shares
derived: average of 4 quarters · filed 2026-08-13
2025-12-314.91M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
4.67M shares
derived: average of 2 quarters · filed 2026-03-30
4.38M shares
derived: average of 3 quarters · filed 2026-08-13
4.15M shares
10-K · filed 2026-03-30
2025-09-304.44M shares
10-Q · filed 2025-11-05
4.12M shares
derived: average of 2 quarters · filed 2026-08-13
3.90M shares
10-Q · filed 2025-11-05
3.71M shares
derived: average of 4 quarters · filed 2026-08-13
2025-06-303.80M shares
10-Q · filed 2026-08-13
3.62M shares
10-Q · filed 2026-08-13
3.46M shares
derived: average of 3 quarters · filed 2026-08-13
3.09M shares
derived: average of 4 quarters · filed 2026-08-13
2025-03-313.44M shares
10-Q · filed 2026-05-14
3.30M shares
derived: average of 2 quarters · filed 2026-05-14
2.86M shares
derived: average of 3 quarters · filed 2026-05-14
2.58M shares
derived: average of 4 quarters · filed 2026-05-14
2024-12-313.15M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
2.57M shares
derived: average of 2 quarters · filed 2026-03-30
2.29M shares
derived: average of 3 quarters · filed 2026-03-30
2.15M shares
10-K · filed 2026-03-30
27.90M shares
10-K · filed 2025-03-27
2024-09-301.99M shares
10-Q · filed 2025-11-05
25.81M shares
10-Q · filed 2024-11-12
1.86M shares
derived: average of 2 quarters · filed 2025-11-05
1.81M shares
10-Q · filed 2025-11-05
23.54M shares
10-Q · filed 2024-11-12
6.23M shares
derived: average of 4 quarters · filed 2025-11-05
2024-06-301.73M shares
10-Q · filed 2025-08-11
22.55M shares
10-Q · filed 2024-08-08
1.72M shares
10-Q · filed 2025-08-11
22.39M shares
10-Q · filed 2024-08-08
7.64M shares
derived: average of 3 quarters · filed 2025-08-11
9.26M shares
derived: average of 4 quarters · filed 2025-08-11
2024-03-311.71M shares
10-Q · filed 2025-05-13
22.23M shares
10-Q · filed 2024-05-09
10.60M shares
derived: average of 2 quarters · filed 2025-05-13
11.77M shares
derived: average of 3 quarters · filed 2025-05-13
12.36M shares
derived: average of 4 quarters · filed 2025-05-13
2023-12-3119.49M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
16.80M shares
derived: average of 2 quarters · filed 2025-03-27
15.90M shares
derived: average of 3 quarters · filed 2025-03-27
15.42M shares
10-K · filed 2025-03-27
2023-09-3014.12M shares
10-Q · filed 2024-11-12
14.11M shares
derived: average of 2 quarters · filed 2024-11-12
14.06M shares
10-Q · filed 2024-11-12
13.93M shares
derived: average of 4 quarters · filed 2024-11-12
2023-06-3014.10M shares
10-Q · filed 2024-08-08
13.93M shares
10-Q · filed 2024-08-08
13.87M shares
derived: average of 3 quarters · filed 2024-08-08
13.81M shares
derived: average of 4 quarters · filed 2024-08-08
2023-03-3113.76M shares
10-Q · filed 2024-05-09
13.76M shares
derived: average of 2 quarters · filed 2024-05-09
13.72M shares
derived: average of 3 quarters · filed 2024-05-09
13.18M shares
derived: average of 4 quarters · filed 2024-05-09
2022-12-3113.75M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
13.69M shares
derived: average of 2 quarters · filed 2024-03-19
12.99M shares
derived: average of 3 quarters · filed 2024-03-19
11.55M shares
10-K · filed 2024-03-19
2022-09-3013.64M shares
10-Q · filed 2023-11-08
12.60M shares
derived: average of 2 quarters · filed 2023-11-08
10.82M shares
10-Q · filed 2023-11-08
9.83M shares
derived: average of 4 quarters · filed 2023-11-08
2022-06-3011.57M shares
10-Q · filed 2023-08-10
9.38M shares
10-Q · filed 2023-08-10
8.56M shares
derived: average of 3 quarters · filed 2023-08-10
8.10M shares
derived: average of 4 quarters · filed 2023-08-10
2022-03-317.17M shares
10-Q · filed 2023-05-10
7.05M shares
derived: average of 2 quarters · filed 2023-05-10
6.94M shares
derived: average of 3 quarters · filed 2023-05-10
5.44M shares
derived: average of 4 quarters · filed 2023-05-10
2021-12-316.94M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
6.83M shares
derived: average of 2 quarters · filed 2023-03-22
4.86M shares
derived: average of 3 quarters · filed 2023-03-22
3.79M shares
10-K · filed 2023-03-22
2021-09-306.72M shares
10-Q · filed 2022-11-08
6.72M shares
10-Q · filed 2021-11-10
3.82M shares
derived: average of 2 quarters · filed 2022-11-08
2.74M shares
10-Q · filed 2022-11-08
2.75M shares
10-Q · filed 2021-11-10
2.12M shares
derived: average of 4 quarters · filed 2022-11-08
2021-06-30925.43K shares
10-Q · filed 2022-08-15
717.62K shares
10-Q · filed 2022-08-15
582.79K shares
derived: average of 3 quarters · filed 2022-08-15
567.45K shares
derived: average of 4 quarters · filed 2022-08-15
2021-03-31507.45K shares
10-Q · filed 2022-05-13
411.48K shares
derived: average of 2 quarters · filed 2022-05-13
448.12K shares
derived: average of 3 quarters · filed 2022-05-13
2020-12-31315.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
418.46K shares
derived: average of 2 quarters · filed 2022-03-29
468.16K shares
10-K · filed 2022-03-29
2020-09-30521.41K shares
10-Q · filed 2021-11-10
519.05K shares
10-Q · filed 2021-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
BIOVIE INC. (BIVI)United States$0.012B
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B